Background The value of continuous glucose monitoring in themanagement of type 1 diabetes mellitus has not been determined.
Methods In a multicenter clinical trial, we randomly assigned322 adults and children who were already receiving intensivetherapy for type 1 diabetes to a group with continuous glucosemonitoring or to a control group performing home monitoringwith a blood glucose meter. All the patients were stratifiedinto three groups according to age and had a glycated hemoglobinlevel of 7.0 to 10.0%. The primary outcome was the change inthe glycated hemoglobin level at 26 weeks.
Results The changes in glycated hemoglobin levels in the twostudy groups varied markedly according to age group (P=0.003),with a significant difference among patients 25 years of ageor older that favored the continuous-monitoring group (meandifference in change, –0.53%; 95% confidence interval[CI], –0.71 to –0.35; P<0.001). The between-groupdifference was not significant among those who were 15 to 24years of age (mean difference, 0.08; 95% CI, –0.17 to0.33; P=0.52) or among those who were 8 to 14 years of age (meandifference, –0.13; 95% CI, –0.38 to 0.11; P=0.29).Secondary glycated hemoglobin outcomes were better in the continuous-monitoringgroup than in the control group among the oldest and youngestpatients but not among those who were 15 to 24 years of age.The use of continuous glucose monitoring averaged 6.0 or moredays per week for 83% of patients 25 years of age or older,30% of those 15 to 24 years of age, and 50% of those 8 to 14years of age. The rate of severe hypoglycemia was low and didnot differ between the two study groups; however, the trialwas not powered to detect such a difference.
Conclusions Continuous glucose monitoring can be associatedwith improved glycemic control in adults with type 1 diabetes.Further work is needed to identify barriers to effectivenessof continuous monitoring in children and adolescents. (ClinicalTrials.govnumber, NCT00406133
[ClinicalTrials.gov]
.)
Source Information
The members of the writing committee (William V. Tamborlane, M.D., Roy W. Beck, M.D., Ph.D., Bruce W. Bode, M.D., Bruce Buckingham, M.D., H. Peter Chase, M.D., Robert Clemons, M.D., Rosanna Fiallo-Scharer, M.D., Larry A. Fox, M.D., Lisa K. Gilliam, M.D., Ph.D., Irl B. Hirsch, M.D., Elbert S. Huang, M.D., M.P.H., Craig Kollman, Ph.D., Aaron J. Kowalski, Ph.D., Lori Laffel, M.D., M.P.H., Jean M. Lawrence, Sc.D., M.P.H., M.S.S.A., Joyce Lee, M.D., M.P.H., Nelly Mauras, M.D., Michael O'Grady, Ph.D., Katrina J. Ruedy, M.S.P.H., Michael Tansey, M.D., Eva Tsalikian, M.D., Stuart Weinzimer, M.D., Darrell M. Wilson, M.D., Howard Wolpert, M.D., Tim Wysocki, Ph.D., and Dongyuan Xing, M.P.H.) assume responsibility for the overall content and integrity of the article. This article (10.1056/NEJMoa0805017) was published at www.nejm.org on September 8, 2008.
Address reprint requests to Dr. Beck at the Jaeb Center for Health Research, 15310 Amberly Dr., #350, Tampa, FL 33647, or at rbeck{at}jaeb.org.
Continuous Glucose Monitoring and Type 1 Diabetes
Montagnana M., Lippi G., Guidi G. C., Finlayson A. E.T., Cronin N. J., Choudhary P., Tamborlane W. V., Beck R. W., Laffel L., the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Extract |
Full Text |
PDF
N Engl J Med 2009;
360:190-192, Jan 8, 2009.
Correspondence
This article has been cited by other articles:
Dinneen, S. F, Dennedy, M C., Muthusamy, K., Smith, S. A
(2009). Minimally invasive and conventional glucose monitoring did not differ for long-term glycaemic control in insulin-treated diabetes. Evid. Based Med.
14: 169-170
[Full Text]
Raccah, D., Sulmont, V., Reznik, Y., Guerci, B., Renard, E., Hanaire, H., Jeandidier, N., Nicolino, M.
(2009). Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study. Diabetes Care
32: 2245-2250
[Abstract][Full Text]
Hood, K. K., Peterson, C. M., Rohan, J. M., Drotar, D.
(2009). Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes: A Meta-analysis. Pediatrics
124: e1171-e1179
[Abstract][Full Text]
American Association of Diabetes Educators,
(2009). AADE Guidelines for the Practice of Diabetes Self-Management Education and Training (DSME/T). The Diabetes Educator
35: 85S-107S
[Full Text]
Juvenile Diabetes Research Foundation Continuous G,
(2009). Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes. Diabetes Care
32: 1947-1953
[Abstract][Full Text]
The Juvenile Diabetes Research Foundation Continuo,
(2009). Sustained Benefit of Continuous Glucose Monitoring on A1C, Glucose Profiles, and Hypoglycemia in Adults With Type 1 Diabetes. Diabetes Care
32: 2047-2049
[Abstract][Full Text]
de Leiva, A., Hernando, M. E., on behalf of EDUAB-HSP and GBT-UPM,
(2009). Telemedical Artificial Pancreas: PARIS (Pancreas Artificial Telemedico Inteligente) research project. Diabetes Care
32: S211-S216
[Full Text]
Leney, S. E, Tavare, J. M
(2009). The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol
203: 1-18
[Abstract][Full Text]
Riveline, J.-P., Teynie, J., Belmouaz, S., Franc, S., Dardari, D., Bauwens, M., Caudwell, V., Ragot, S., Bridoux, F., Charpentier, G., Marechaud, R., Hadjadj, S.
(2009). Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant
24: 2866-2871
[Abstract][Full Text]
Borel, A.-L., Benhamou, P.-Y., Baguet, J.-P., Debaty, I., Levy, P., Pepin, J.-L., Mallion, J.-M.
(2009). Short Sleep Duration Is Associated With a Blood Pressure Nondipping Pattern in Type 1 Diabetes: The DIAPASOM study. Diabetes Care
32: 1713-1715
[Abstract][Full Text]
Amiel, S. A.
(2009). Hypoglycemia: From the Laboratory to the Clinic. Diabetes Care
32: 1364-1371
[Full Text]
Juvenile Diabetes Research Foundation Continuous G,
(2009). The Effect of Continuous Glucose Monitoring in Well-Controlled Type 1 Diabetes. Diabetes Care
32: 1378-1383
[Abstract][Full Text]
Hirsch, I. B.
(2009). Realistic Expectations and Practical Use of Continuous Glucose Monitoring for the Endocrinologist. J. Clin. Endocrinol. Metab.
94: 2232-2238
[Abstract][Full Text]
Saudek, C. D.
(2009). Can Diabetes Be Cured?: Potential Biological and Mechanical Approaches. JAMA
301: 1588-1590
[Full Text]
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., Service, F. J.
(2009). Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab.
94: 709-728
[Abstract][Full Text]
Garg, S. K., Voelmle, M. K., Gottlieb, P.
(2009). Feasibility of 10-Day Use of a Continuous Glucose-Monitoring System in Adults With Type 1 Diabetes. Diabetes Care
32: 436-438
[Abstract][Full Text]
Bratton, S. L.
(2009). Early Insulin Therapy in Very-Low-Birthweight Infants. AAP Grand Rounds
21: 20-20
[Full Text]
Montagnana, M., Lippi, G., Guidi, G. C., Finlayson, A. E.T., Cronin, N. J., Choudhary, P., Tamborlane, W. V., Beck, R. W., Laffel, L., the Juvenile Diabetes Research Foundation Continuo,
(2009). Continuous Glucose Monitoring and Type 1 Diabetes. NEJM
360: 190-192
[Full Text]
American Diabetes Association,
(2009). Standards of Medical Care in Diabetes--2009. Diabetes Care
32: S13-S61
[Full Text]
(2008). Improving Glycosylated Hemoglobin Levels in Children with Diabetes. JWatch Pediatrics
2008: 1-1
[Full Text]
(2008). Continuous Glucose Monitoring in Type 1 Diabetes. JWatch General
2008: 4-4
[Full Text]